Syros Pharmaceuticals, Inc. (SYRS)
NASDAQ: SYRS · IEX Real-Time Price · USD
4.720
-0.390 (-7.63%)
At close: Apr 18, 2024, 4:00 PM
4.740
+0.020 (0.42%)
After-hours: Apr 18, 2024, 5:50 PM EDT
Syros Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for SYRS stock have an average target of 14.33, with a low estimate of 13 and a high estimate of 15. The average target predicts an increase of 203.60% from the current stock price of 4.72.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SYRS stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $13 | Buy | Reiterates | $13 | +175.42% | Apr 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +217.80% | Apr 1, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $11 → $7 | Buy | Maintains | $11 → $7 | +48.31% | Oct 3, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +217.80% | Aug 9, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +217.80% | May 11, 2023 |
Financial Forecast
Revenue This Year
2.86M
from 9.94M
Decreased by -71.26%
Revenue Next Year
32.72M
from 2.86M
Increased by 1,045.73%
EPS This Year
-3.76
from -5.81
EPS Next Year
-3.41
from -3.76
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.4M | 136.9M | 345.7M | 1.3B | 1.7B |
| Avg | 2.9M | 32.7M | 154.2M | 641.2M | 893.7M |
| Low | n/a | n/a | 38.5M | 254.8M | 369.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -26.0% | 4,694.1% | 956.4% | 758.0% | 170.5% |
| Avg | -71.3% | 1,045.7% | 371.2% | 315.8% | 39.4% |
| Low | - | - | 17.7% | 65.3% | -42.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.94 | -1.10 | 2.04 | 19.03 | 27.56 |
| Avg | -3.76 | -3.41 | -1.44 | 12.10 | 16.34 |
| Low | -4.67 | -4.84 | -3.98 | 5.49 | 5.67 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 127.8% |
| Avg | - | - | - | - | 35.1% |
| Low | - | - | - | - | -53.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.